Stocks
AxoGen, Inc.AXGN
NASDAQHealthcareMedical Devices$32.34+1.83%
Specializing in peripheral nerve regeneration and repair, this company develops and markets surgical solutions for nerve injuries. Its portfolio includes nerve connectors, protectants, and allografts, positioning it as a key player in the niche neurosurgery market. Investors monitor AxoGen for its growth potential in the expanding field of nerve repair technologies.
Market Cap: $1.7B52W Range: $9.22 – $36.00
Congressional Interest in AxoGen, Inc. (AXGN)
1 member of Congress has disclosed 2 trades in AxoGen, Inc. (AXGN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading AXGN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-06-24 | Donna Shalala | sell | $1K – $15K |
| 2019-04-16 | Donna Shalala | buy | $1K – $15K |